Sign Out
Treatment of hypercholesterolemia: Adults, adolescent and children aged 10 years or older with primary hypercholesterolemia (type II A including heterozygous familial hypercholesterolemia) or mixed dyslipidemia (type II B) as an adjunct to diet when response to diet and other non-pharmacological treatments (e.g. exercise, weight reduction) is inadequate. Homozygous familial hypercholesterolemia as an adjunct to diet and other lipid lowering treatments (e.g. LDL apheresis) or if such treatment is not appropriate.
Prevention of Cardiovascular Events: Prevention of major cardiovascular events in patients who are estimated to have a high risk for a first cardiovascular events as an adjunct to correction of other risk factors.
